Cartilage Damage – Focus Health
Article by Prof. Dr. med. habil. Peter Diehl
Cartilage damage in the knee is very common, and not just among older people. Younger age groups also struggle with osteoarthritis. Injuries sustained by athletes years ago can often lead to severe cartilage damage. This was also the case for Herbert Brenner. A patient at the Munich East Orthopedic Center, whose success story was featured in *Focus Gesundheit*. You can read about it in the current issue, 5/2023. The 52-year-old was injured 20 years ago while playing ice hockey and, as a result, had to contend with grade-3 osteoarthritis in his knee, which made every step a torment. Thanks to modern cartilage medicine and OZMO expert Prof. Peter Diehl, Herbert Brenner was spared the need for a joint replacement and is now able to play sports again.
Prof. Dr. med. habil. Peter Diehl ist Facharzt für Orthopädie und Unfallchirurgie am OZMO – Orthopädie Zentrum München Ost. Als Spezialist für Schulter- und Knieerkrankungen verfügt er über langjährige operative Erfahrung. Zu seinen Behandlungsschwerpunkten zählen Sportverletzungen, Knorpelschäden, regenerative Knorpeltherapien und minimalinvasive Gelenkeingriffe.
Gold Standard: The Body’s Own Cells
One of the most well-established methods—and now the gold standard—is the cultivation and transplantation of the body’s own cells, known as autologous chondrocyte transplantation (ACT). This is particularly effective when larger areas of the joint cartilage are involved; up to ten square centimeters can be replaced.
ACT—Autologous Chondrocyte Transplantation
The ACT procedure has been performed since the 1990s and has continued to evolve over time. The procedure involves several steps. First, during arthroscopy, healthy tissue is harvested from a low-stress area of the patient’s knee. The cells isolated from this tissue are then cultured in the laboratory to ensure a sufficient yield for treatment. This process can take several weeks. Once enough cells are available, they are implanted into the damaged knee joint, precisely targeting the prepared lesion. This is done either arthroscopically or through a small incision in the joint. The procedure takes no more than one hour and is performed under local anesthesia. The major advantage of this method is that the patient’s own cells, thanks to their regenerative potential, help form new cartilage at the site and, most importantly, repair the damaged cartilage. Following the surgery, patients are provided with crutches but begin gentle mobilization immediately. After five to six weeks, patients can partially bear weight again; full strength is achieved after three months. Light exercise is then permitted again. Jogging is usually approved after 6 months, and soccer or skiing after one year.
Another advantage of ACT is that it reduces the risk of rejection or other complications. Since the cells come from the patient’s own body, rejection is unlikely.
Cartilage cell transplantation has proven effective
The prospects for success are therefore very good. Cartilage cell transplantation has proven effective for extensive cartilage damage in the knee or ankle. But the procedure also works exceptionally well on the hip, shoulder, or elbow. Patients who have undergone the procedure report improvements shortly after surgery. Once the transplanted cartilage cells have generated sufficient new cartilage mass in the joint after several months, the joint is once again nearly as resilient as it was when healthy.
Patient Herbert Brenner is happy today to be able to play sports again after his successful transplant—and without any symptoms.
The procedure not only sounds very challenging—it actually is—which is why health insurance companies only cover the therapy at designated centers. However—and this is a testament to the therapy’s strong reputation since 2023—it can also be performed on an outpatient basis even in severe cases. It is very important to determine in advance whether the patient is a suitable candidate for the ACT method. This depends on various factors, such as the extent of cartilage damage, the patient’s age, and other individual factors.
Conclusion: Therapy using the body’s own cells shows great promise
In conclusion, it’s safe to say that therapy using the body’s own cells is a promising treatment method for cartilage damage in the knee, shoulder, hip, or elbow. By using the body’s own cells, the damaged cartilage in the knee can be regenerated and the function of the knee joint improved. However, treatment should be started early. If the joints are already severely damaged on both sides, it is often too late for biological cartilage regeneration.
Please feel free to ask us about the ACT method, which allowed OZMO patient Herbert Brenner to avoid needing an artificial joint.
Read his success story now in *Focus Gesundheit*, Issue 5/2023





